See more : Eurotech S.p.A. (ERTWF) Income Statement Analysis – Financial Results
Complete financial analysis of TAAT Global Alternatives Inc. (TOBAF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of TAAT Global Alternatives Inc., a leading company in the Tobacco industry within the Consumer Defensive sector.
You may be interested
- CRG Holdings Co.,Ltd. (7041.T) Income Statement Analysis – Financial Results
- Northfield Precision Instrument Corp. (NFPC) Income Statement Analysis – Financial Results
- Finolex Industries Limited (FINPIPE.NS) Income Statement Analysis – Financial Results
- Exel Composites Oyj (EXL1V.HE) Income Statement Analysis – Financial Results
- Gentian Diagnostics ASA (GENT.OL) Income Statement Analysis – Financial Results
TAAT Global Alternatives Inc. (TOBAF)
About TAAT Global Alternatives Inc.
TAAT Global Alternatives Inc., through its subsidiary, TAAT International LLC, manufactures and distributes hemp cigarettes under the Wild Hemp brand name in Canada and the United States. The company was formerly known as TAAT Lifestyle & Wellness Ltd. and changed its name to TAAT Global Alternatives Inc. in April 2021. TAAT Global Alternatives Inc. was incorporated in 2006 and is headquartered in Vancouver, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 94.62M | 42.54M | 2.56M | 171.19K | 0.00 | 0.00 | 889.77K | 149.45K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 92.11M | 38.79M | 1.66M | 100.94K | 18.92K | 15.20K | 1.05M | 204.45K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 2.51M | 3.74M | 905.36K | 70.25K | -18.92K | -15.20K | -163.00K | -55.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 2.65% | 8.80% | 35.36% | 41.04% | 0.00% | 0.00% | -18.32% | -36.80% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 45.17K | 238.27K | 505.96K | 183.43K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 4.36M | 23.86M | 24.56M | 8.08M | 963.00K | 977.11K | 1.34M | 1.50M | 1.26M | 3.20M | 2.70M | 946.74K | 81.45K | 171.63K | 128.64K | 74.52K | 0.00 | 0.00 |
| Selling & Marketing | 251.22K | 2.08M | 8.11M | 1.41M | 70.29K | 99.46K | 552.85K | -17.07K | 305.92K | 635.71K | 270.08K | 24.28K | 32.54K | 6.50K | 9.70K | 3.76K | 0.00 | 0.00 |
| SG&A | 9.10M | 25.94M | 32.67M | 9.50M | 1.03M | 1.08M | 1.90M | 1.50M | 1.57M | 3.84M | 2.97M | 971.02K | 113.99K | 178.12K | 138.33K | 78.27K | 82.38K | 3.99K |
| Other Expenses | 0.00 | 1.86M | 583.46K | 119.49K | -540.63K | 76.65K | 0.00 | 17.07K | 136.25K | 94.20K | 12.73M | 1.33M | 624.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 9.14M | 28.03M | 33.76M | 9.80M | 492.67K | 1.60M | 1.90M | 1.50M | 1.70M | 3.87M | 15.77M | 2.30M | 114.62K | 178.12K | 138.33K | 78.27K | 82.38K | 3.99K |
| Cost & Expenses | 101.25M | 66.83M | 35.42M | 9.90M | 492.67K | 1.60M | 2.96M | 1.70M | 1.70M | 3.87M | 15.77M | 2.30M | 114.62K | 178.12K | 138.33K | 78.27K | 82.38K | 3.99K |
| Interest Income | 9.46K | 226.47K | 671.00 | 23.68K | 705.00 | 1.09K | 1.21K | 5.26K | 0.00 | 0.00 | 0.00 | 0.00 | 8.97K | 7.75K | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 742.74K | 226.47K | 145.70K | 23.68K | 12.72K | 10.61K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 303.00 | 800.00 | 423.00 | 203.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 1.55M | 1.56M | 583.46K | 119.49K | 18.92K | 15.20K | 7.22K | 94.93K | 11.95M | 8.88K | -35.61K | 0.00 | 9.27K | 8.55K | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA | -7.77M | -22.85M | -32.63M | -11.14M | -1.01M | -1.57M | -1.84M | -1.46M | 10.24M | -3.61M | -15.73M | -2.30M | -105.32K | -170.38K | -138.33K | -78.27K | -82.38K | -3.99K |
| EBITDA Ratio | -8.21% | -53.07% | -1,260.20% | -5,613.74% | 0.00% | 0.00% | -206.72% | -3,536.07% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -6.63M | -24.14M | -32.85M | -9.73M | -454.22K | -1.60M | -2.06M | -1.54M | -1.70M | -3.75M | -15.70M | -2.30M | -114.92K | -178.92K | -138.33K | -78.27K | -82.38K | -3.99K |
| Operating Income Ratio | -7.01% | -56.74% | -1,282.99% | -5,683.54% | 0.00% | 0.00% | -231.46% | -1,028.43% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -4.36M | -3.56M | -6.25M | -1.73M | 536.15K | -35.20K | 77.62K | 3.83M | -11.95M | -405.07K | -156.96K | 101.01K | 8.97K | -348.21K | -423.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax | -11.00M | -24.63M | -33.36M | -11.29M | -468.95K | -1.60M | -1.98M | 2.29M | -13.65M | -4.02M | -15.81M | -2.20M | -105.95K | -527.13K | -138.76K | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | -11.62% | -57.91% | -1,302.88% | -6,592.37% | 0.00% | 0.00% | -222.74% | 1,534.82% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 120.97K | 270.68K | 145.70K | -85.27K | 50.47K | 4.88M | -84.84K | -3.83M | 2.00 | 242.72K | 71.90K | 0.00 | 0.00 | -56.21K | 138.76K | 78.48K | 82.64K | 4.02K |
| Net Income | -11.12M | -24.90M | -33.51M | -11.20M | -519.41K | -6.48M | -1.98M | 2.29M | -13.65M | -4.02M | -15.81M | -2.20M | -105.95K | -470.92K | -138.76K | -78.48K | -82.64K | -4.02K |
| Net Income Ratio | -11.75% | -58.55% | -1,308.57% | -6,542.56% | 0.00% | 0.00% | -222.74% | 1,534.82% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -1.00 | -2.39 | -3.52 | -1.93 | -0.28 | -6.76 | -3.09 | 8.80 | -51.76 | -16.60 | -77.14 | -20.03 | -1.35 | -8.32 | -9.23 | -5.22 | -6.57 | -0.54 |
| EPS Diluted | -1.00 | -2.39 | -3.52 | -1.93 | -0.28 | -6.76 | -3.09 | 8.00 | -51.76 | -16.60 | -77.14 | -20.03 | -1.35 | -8.32 | -9.23 | -5.22 | -6.57 | -0.54 |
| Weighted Avg Shares Out | 11.09M | 10.44M | 9.51M | 5.80M | 1.88M | 959.31K | 640.47K | 263.72K | 263.72K | 242.25K | 204.93K | 110.03K | 78.44K | 56.63K | 15.04K | 15.03K | 12.58K | 7.50K |
| Weighted Avg Shares Out (Dil) | 11.09M | 10.44M | 9.51M | 5.80M | 1.88M | 959.31K | 640.47K | 286.73K | 263.72K | 242.25K | 204.93K | 110.03K | 78.44K | 56.63K | 15.04K | 15.03K | 12.58K | 7.50K |
Beyond Alternatives Company of TAAT® to Launch “Jayvees” Brand at CHAMPS Las Vegas Trade Show
Beyond Alternatives' inaugural brand “Jayvees” will be launched at the CHAMPS Las Vegas trade show starting on Wednesday, February 8, 2023, featuring an initial selection of combustible and edible products made using novel cannabinoids. Jayvees is the first new brand...
TAAT® Provides Year-End Update
In lieu of the previously scheduled investor call on December 15, 2022, the Company provides a comprehensive year-end update on its business operations with a special emphasis on the six months following the appointment of Michael Saxon as its Chief...
TAAT® Products to Expand in Austin, TX with GAMA Partnership
LAS VEGAS and VANCOUVER, British Columbia, Oct. 18, 2022 (GLOBE NEWSWIRE) -- TAAT® GLOBAL ALTERNATIVES INC. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) (the “Company” or “TAAT®”) is pleased to announce that starting in November 2022 TAAT® Original, Smooth, and Menthol...
TAAT® Hosting Exhibitor Booth and Two Private Events at the 2022 NACS Show in Las Vegas
LAS VEGAS and VANCOUVER, British Columbia, Sept. 30, 2022 (GLOBE NEWSWIRE) -- TAAT® GLOBAL ALTERNATIVES INC. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) (the “Company” or “TAAT®”) is pleased to announce that it will be hosting an exhibitor booth at the...
REPEAT – TAAT® Announces Fiscal Third Quarter 2022 Results Anchored by Over CAD $17.4 Million in Revenue
LAS VEGAS and VANCOUVER, British Columbia, Sept. 22, 2022 (GLOBE NEWSWIRE) -- TAAT® GLOBAL ALTERNATIVES INC. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) (the “Company” or “TAAT®”) today announced its financial results for the three-month period ended July 31, 2022, its...
TAAT® Announces Fiscal Third Quarter 2022 Results Anchored by Over CAD $17.4 Million in Revenue
LAS VEGAS and VANCOUVER, British Columbia, Sept. 21, 2022 (GLOBE NEWSWIRE) -- TAAT® GLOBAL ALTERNATIVES INC. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) (the “Company” or “TAAT®”) today announced its financial results for the three-month period ended July 31, 2022, its...
REPEAT – TAAT® Hosting Live Earnings Call at 4:30 pm Eastern on Wednesday September 21
This earnings call was originally scheduled to take place on Thursday, September 22, 2022 at 4:15 pm (Eastern). The earnings call to take place on Wednesday, September 21, 2022 at 4:30 pm (Eastern) replaces the originally scheduled event.
TAAT® Hosting Live Earnings Call at 4:30 pm Eastern on Wednesday September 21
This earnings call was originally scheduled to take place on Thursday, September 22, 2022 at 4:15 pm (Eastern). The earnings call to take place on Wednesday, September 21, 2022 at 4:30 pm (Eastern) replaces the originally scheduled event.
REPEAT – TAAT® Dispatches Largest U.K. Shipment to Date for Expanded Distribution
With the largest U.K. shipment of TAAT® to date now set to arrive this quarter, the Company's U.K. TAAT® distributor plans to expand the brand's footprint into other markets in the southeastern region of the country.
TAAT® Dispatches Largest U.K. Shipment to Date for Expanded Distribution
With the largest U.K. shipment of TAAT® to date now set to arrive this quarter, the Company's U.K. TAAT® distributor plans to expand the brand's footprint into other markets in the southeastern region of the country.
Source: https://incomestatements.info
Category: Stock Reports